Endoret® (PRGF®) technology is suitable for the treatment of muscle injuries. Its application as an outpatient procedure reduces the recovery time for this type of injury with an almost zero rate of recurrence.
Endoret® (PRGF®) contains multiple growth factors that stimulate different steps of myogenesis, including proliferation, differentiation, migration and the fusion of muscle cells.
Reduces pain and swelling
Reduces the healing time
Reduces the rate of recurrence
Clinical efficacy in tendinopathy and ligament injuries confirmed by publications using Endoret® (PRGF®) technology